Featured Research

from universities, journals, and other organizations

Researchers Refocus Studies On Patients With HIV, Hepatitis

Date:
October 12, 2006
Source:
UT Southwestern Medical Center
Summary:
As HIV patients live longer thanks to advanced therapies, researchers are looking for better ways to treat accompanying maladies such as hepatitis that traditionally were not emphasized.

Dr. Mamta Jain, assistant professor of internal medicine, is involved in several ongoing clinical trials involving HIV patients. The latest study involves whether giving hepatitis C, or HCV, medications early on during HIV disease speeds recovery or improves hepatitis therapies.
Credit: UT Southwestern Medical Center

As HIV patients live longer thanks to advanced therapies, researchers are looking for better ways to treat accompanying maladies such as hepatitis that traditionally were not emphasized.

"People are living longer with HIV now, but then we see people developing complications from liver disease due to hepatitis," said Dr. Mamta Jain, assistant professor of internal medicine at UT Southwestern Medical Center. "Before we had effective HIV therapy, there was no interest in treating hepatitis C because the thought was the patient would die of AIDS. Well, they're not dying of AIDS, so we are making an effort to try to treat more patients for hepatitis C."

Other diseases, such as cirrhosis or hepatocellular cancers, progress faster in co-infected HIV and hepatitis patients. As a result, health-care providers are trying to intervene as early as possible, said Dr. Jain, who specializes in infectious diseases.

Dr. Jain oversees a co-infection clinic at Parkland Memorial Hospital where patients are evaluated for hepatitis and HIV and can participate in clinical trials. Generally, co-infection rates range from 10 percent to 33 percent of HIV patients. Rates run at about 25 percent at the clinic in Parkland, which is the teaching hospital for UT Southwestern.

UT Southwestern has several ongoing clinical trials for which doctors are recruiting potential patients. The latest study involves whether giving hepatitis C, or HCV, medications early on during HIV disease speeds recovery or improves hepatitis therapies.

"We are trying to determine whether we can improve the response to hepatitis treatment with interferon and ribavirin therapy in co-infected patients if we give them these HIV medications early on," Dr. Jain said. "It may change how we treat hepatitis C or it may change how we treat HIV because it may suggest that we treat HIV earlier."

Some HIV therapies designed to slow the HIV infection can also slow the spread of the hepatitis B virus, or HBV.

Dr. Jain recently completed a study showing little difference between treating HIV/HBV co-infected patients with a single drug as compared to giving two drugs that are used for both conditions -- lamivudine and tenofovir.

But the research also hinted at possible evidence that the strain, or genotype, of the hepatitis B virus infecting a patient may indicate which therapies will work better on that individual. The genotype is the genetic code of the virus, and there are eight different genotypes of HBV. The most common genotype in the United States is genotype A, which the study noted responded better to therapy.

"Patients infected with non-A genotypes didn't seem to respond as well to therapy," Dr. Jain said.

Further studies will be needed to determine whether genotype truly is a reliable indicator, she said.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Researchers Refocus Studies On Patients With HIV, Hepatitis." ScienceDaily. ScienceDaily, 12 October 2006. <www.sciencedaily.com/releases/2006/10/061012090122.htm>.
UT Southwestern Medical Center. (2006, October 12). Researchers Refocus Studies On Patients With HIV, Hepatitis. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2006/10/061012090122.htm
UT Southwestern Medical Center. "Researchers Refocus Studies On Patients With HIV, Hepatitis." ScienceDaily. www.sciencedaily.com/releases/2006/10/061012090122.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins